Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT06694142
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Sexual Dysfunction
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Rosy app — BEHAVIORALParticipants will be provided a six-month membership subscription to the mobile application ROSY. ROSY will recommend pathways for addressing issues through 1) coaching by board certified coaches or 2) joining a completely anonymous community with other people where they can share experiences and get help as new members of the community to overcome sexual health challenges .Users will work towards their health goals each day using tools from medical and mental health experts . Tools used include 1) virtual workshops and 2) coaching sessions which will provide the opportunity to a) Have an authentic and relatable conversation with an expert b) Explore new pathways to better health experience c) Improve their relationship with themselves, partner, and healthcare providers d) Learn fun ways to improve their everyday wellness e) Access live events from anywhere.
Study Details
The purpose of this study is to identify breast and gynecologic cancer patients with sexual dysfunction, to measure sexual dysfunction with the Female Sexual Function Index (FSFI) and to provide Patients with the opportunity during this six-month period to follow up with a healthcare provider to discuss the sexual dysfunction needs and to see if a medical intervention can be of aid.
Key Dates
- Start date
- Nov 18, 2024
- Status verified
- Nov 2024
- Primary completion
- Nov 18, 2025
- Completion
- May 18, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Rosy app
Primary Outcome Measure
Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI) [ Time Frame: Baseline, 6 months ]
Central Contacts
- Lavanya P Parsons, MD(713) 500-6440
- Ayokunle Ogunye(713) 500-6410
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
Related Studies
- Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post MenopauseNot Yet Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute ConditionsPHASE1/PHASE2 · Recruiting · Thomas Advanced Medical LLC · Culver City, California
- Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple SclerosisNot Yet Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Prostate Stimulation for Sexual DysfunctionRecruiting · Stanford University · Stanford, California